UA80144C2 - Піперидин-2,6-діон памоатні солі і їх застосування для лікування пов'язаних зі стресом афективних розладів - Google Patents
Піперидин-2,6-діон памоатні солі і їх застосування для лікування пов'язаних зі стресом афективних розладів Download PDFInfo
- Publication number
- UA80144C2 UA80144C2 UAA200501443A UAA200501443A UA80144C2 UA 80144 C2 UA80144 C2 UA 80144C2 UA A200501443 A UAA200501443 A UA A200501443A UA A200501443 A UAA200501443 A UA A200501443A UA 80144 C2 UA80144 C2 UA 80144C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dimethylpiperidine
- sleep
- stress
- differs
- pamoate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0219639.2A GB0219639D0 (en) | 2002-08-22 | 2002-08-22 | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders |
| PCT/IB2003/003698 WO2004017970A1 (en) | 2002-08-22 | 2003-08-18 | Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA80144C2 true UA80144C2 (uk) | 2007-08-27 |
Family
ID=9942831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200501443A UA80144C2 (uk) | 2002-08-22 | 2003-08-18 | Піперидин-2,6-діон памоатні солі і їх застосування для лікування пов'язаних зі стресом афективних розладів |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7514454B2 (no) |
| EP (1) | EP1539160B1 (no) |
| JP (1) | JP2005538146A (no) |
| KR (1) | KR20050038014A (no) |
| CN (1) | CN1678316A (no) |
| AT (1) | ATE330605T1 (no) |
| BR (1) | BR0313674A (no) |
| CA (1) | CA2495377A1 (no) |
| CY (1) | CY1105541T1 (no) |
| DE (1) | DE60306396T2 (no) |
| DK (1) | DK1539160T3 (no) |
| EA (1) | EA007900B1 (no) |
| ES (1) | ES2268474T3 (no) |
| GB (1) | GB0219639D0 (no) |
| GE (1) | GEP20074051B (no) |
| IL (1) | IL166941A (no) |
| MX (1) | MXPA05001919A (no) |
| NO (1) | NO20051471L (no) |
| NZ (1) | NZ538341A (no) |
| PL (1) | PL373416A1 (no) |
| PT (1) | PT1539160E (no) |
| UA (1) | UA80144C2 (no) |
| WO (1) | WO2004017970A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
| GB0518763D0 (en) * | 2005-09-14 | 2005-10-19 | Prestwick Pharmaceuticals Inc | Treatment of hypertension |
| US20090018182A1 (en) * | 2006-06-28 | 2009-01-15 | Sigalit Levi | Crystalline forms of atorvastatin |
| EP2833866B2 (en) | 2012-04-04 | 2024-11-27 | Intervet International B.V. | Soft chewable pharmaceutical products |
| CN105727117A (zh) * | 2016-02-03 | 2016-07-06 | 瓮杰林 | 一种治疗前列腺增生的药物及其制备方法 |
| CN106831594B (zh) * | 2017-01-18 | 2018-02-02 | 力赛生物医药科技(厦门)有限公司 | 可乐定双羟萘酸盐及其制备方法 |
| CN115702894A (zh) * | 2021-08-11 | 2023-02-17 | 朱信红 | 一种用于止吐的缓释组合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
| US4461771A (en) * | 1983-03-01 | 1984-07-24 | Gittos Maurice W | Treatment of migraine with dioxopiperidine derivatives |
| DE3686622T2 (de) * | 1985-09-11 | 1993-04-01 | British Tech Group | Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen. |
| DE3779991T2 (de) | 1986-09-08 | 1993-02-04 | British Tech Group | Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen. |
| GB8716338D0 (en) | 1987-07-10 | 1987-08-19 | Nat Res Dev | Anti-anxiogenic compositions |
| GB2379216A (en) * | 2001-08-28 | 2003-03-05 | Maurice Ward Gittos | Piperidin-2,6-dione salts useful for the treatment of stress-related affective disorders |
-
2002
- 2002-08-22 GB GBGB0219639.2A patent/GB0219639D0/en not_active Ceased
-
2003
- 2003-08-18 EA EA200500242A patent/EA007900B1/ru not_active IP Right Cessation
- 2003-08-18 NZ NZ538341A patent/NZ538341A/en not_active IP Right Cessation
- 2003-08-18 ES ES03792588T patent/ES2268474T3/es not_active Expired - Lifetime
- 2003-08-18 MX MXPA05001919A patent/MXPA05001919A/es active IP Right Grant
- 2003-08-18 JP JP2004530467A patent/JP2005538146A/ja active Pending
- 2003-08-18 WO PCT/IB2003/003698 patent/WO2004017970A1/en not_active Ceased
- 2003-08-18 US US10/524,693 patent/US7514454B2/en not_active Expired - Fee Related
- 2003-08-18 CN CNA038199149A patent/CN1678316A/zh active Pending
- 2003-08-18 PL PL03373416A patent/PL373416A1/xx not_active Application Discontinuation
- 2003-08-18 CA CA002495377A patent/CA2495377A1/en not_active Abandoned
- 2003-08-18 UA UAA200501443A patent/UA80144C2/uk unknown
- 2003-08-18 AT AT03792588T patent/ATE330605T1/de active
- 2003-08-18 PT PT03792588T patent/PT1539160E/pt unknown
- 2003-08-18 DK DK03792588T patent/DK1539160T3/da active
- 2003-08-18 DE DE60306396T patent/DE60306396T2/de not_active Expired - Lifetime
- 2003-08-18 KR KR1020057002687A patent/KR20050038014A/ko not_active Ceased
- 2003-08-18 EP EP03792588A patent/EP1539160B1/en not_active Expired - Lifetime
- 2003-08-18 GE GEAP8650A patent/GEP20074051B/en unknown
- 2003-08-18 BR BR0313674-4A patent/BR0313674A/pt not_active Application Discontinuation
-
2005
- 2005-02-16 IL IL166941A patent/IL166941A/en not_active IP Right Cessation
- 2005-03-21 NO NO20051471A patent/NO20051471L/no not_active Application Discontinuation
-
2006
- 2006-09-15 CY CY20061101323T patent/CY1105541T1/el unknown
-
2009
- 2009-03-18 US US12/382,511 patent/US20090182012A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005538146A (ja) | 2005-12-15 |
| NZ538341A (en) | 2006-09-29 |
| CN1678316A (zh) | 2005-10-05 |
| KR20050038014A (ko) | 2005-04-25 |
| EA007900B1 (ru) | 2007-02-27 |
| DE60306396D1 (de) | 2006-08-03 |
| AU2003255947A1 (en) | 2004-03-11 |
| US20060025443A1 (en) | 2006-02-02 |
| PT1539160E (pt) | 2006-10-31 |
| GB0219639D0 (en) | 2002-10-02 |
| ATE330605T1 (de) | 2006-07-15 |
| PL373416A1 (en) | 2005-08-22 |
| BR0313674A (pt) | 2005-06-21 |
| CY1105541T1 (el) | 2010-07-28 |
| ES2268474T3 (es) | 2007-03-16 |
| MXPA05001919A (es) | 2005-06-03 |
| DE60306396T2 (de) | 2007-05-03 |
| IL166941A (en) | 2010-04-15 |
| WO2004017970A1 (en) | 2004-03-04 |
| EP1539160B1 (en) | 2006-06-21 |
| EA200500242A1 (ru) | 2005-08-25 |
| GEP20074051B (en) | 2007-02-26 |
| NO20051471L (no) | 2005-05-23 |
| CA2495377A1 (en) | 2004-03-04 |
| US7514454B2 (en) | 2009-04-07 |
| EP1539160A1 (en) | 2005-06-15 |
| US20090182012A1 (en) | 2009-07-16 |
| DK1539160T3 (da) | 2006-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW203038B (no) | ||
| US20090182012A1 (en) | Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders | |
| US20050250944A1 (en) | Synthesis and uses of synephrine derivatives | |
| HU190695B (en) | Process for producing 4-methyl-6-phenyl-pyridazine derivatives | |
| US7189742B2 (en) | Piperidin-2,6-dione bisulphate salts and their use for the treatment of stress related affective disorders | |
| JPH0723365B2 (ja) | フエノキシアルキルまたはチオフエノキシアルキル側鎖を有する新規ピペラジンカルボキシアミド化合物 | |
| AU2002321522A1 (en) | Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders | |
| AU2003255947B2 (en) | Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders | |
| HU194847B (en) | Process for producing 1-/acetyl-amino-phenyl/-2-amino-propanone derivatives and salts and pharmaceutical compositions containing them as active components | |
| JPH0558633B2 (no) | ||
| HRP920775A2 (hr) | Novi heterociklični spojevi koji sadrže dušik i sumpor, farmaceutski preparati koji ih sadrže i postupci za dobivanje | |
| SK20795A3 (en) | 1-/2-(1h-indene-3-yl) ethyl/-4-(naphthyl) piperazine derivatives, method of their preparation and pharmaceutical compositions containing these derivatives | |
| EP2393778B1 (en) | Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having CNS activity | |
| EA011280B1 (ru) | Пиперазиновые производные алкилоксиндолов | |
| HK1078034A (en) | Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders | |
| HUP0900062A2 (en) | Novel polymorphs and amorph forms of desvenlafaxine fumarate |